Literature DB >> 34634962

Proceedings of the 2021 National Toxicology Program Satellite Symposium.

Susan A Elmore1, Shambhunath Choudhary2, Gregory A Krane3, Quinci Plumlee4, Erin M Quist5, Andrew W Suttie6, Debra A Tokarz5, Jerrold M Ward7, Michelle Cora1.   

Abstract

The 2021 annual National Toxicology Program (NTP) Satellite Symposium, entitled "Pathology Potpourri," was the 20th anniversary of the symposia and held virtually on June 25th, in advance of the Society of Toxicologic Pathology's 40th annual meeting. The goal of this symposium was to present and discuss challenging diagnostic pathology and/or nomenclature issues. This article presents summaries of the speakers' talks along with select images that were presented to the audience for voting and discussion. Various lesions and topics covered during the symposium included differentiation of canine oligodendroglioma, astrocytoma, and undefined glioma with presentation of the National Cancer Institute's updated diagnostic terminology for canine glioma; differentiation of polycystic kidney, dilated tubules and cystic tubules with a discussion of human polycystic kidney disease; a review of various rodent nervous system background lesions in control animals from NTP studies with a focus on incidence rates and potential rat strain differences; vehicle/excipient-related renal lesions in cynomolgus monkeys with a discussion on the various cyclodextrins and their bioavailability, toxicity, and tumorigenicity; examples of rodent endometrial tumors including intestinal differentiation in an endometrial adenocarcinoma that has not previously been reported in rats; a review of various rodent adrenal cortex lesions including those that represented diagnostic challenges with multiple processes such as vacuolation, degeneration, necrosis, hyperplasia, and hypertrophy; and finally, a discussion of diagnostic criteria for uterine adenomyosis, atypical hyperplasia, and adenocarcinoma in the rat.

Entities:  

Keywords:  NTP Satellite Symposium; adrenal cortex lesions; cyclodextrin; endometrial adenocarcinoma; polycystic kidney; spontaneous glioma; uterine adenomyosis

Mesh:

Year:  2021        PMID: 34634962      PMCID: PMC8563405          DOI: 10.1177/01926233211043497

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  47 in total

1.  Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications.

Authors:  William K Funkhouser; D Neil Hayes; Dominic T Moore; W Keith Funkhouser; Jason P Fine; HeeJoon Jo; Nana Nikolaishvilli-Feinberg; Mervi Eeva; Juneko E Grilley-Olson; Peter M Banks; Paolo Graziano; Elizabeth L Boswell; Goran Elmberger; Kirtee Raparia; Craig F Hart; Lynette M Sholl; Norris J Nolan; Karen J Fritchie; Ersie Pouagare; Timothy C Allen; Keith E Volmar; Paul W Biddinger; Daniel T Kleven; Michael J Papez; Deborah V Spencer; Natasha Rekhtman; Mari Mino-Kenudson; Lida Hariri; Brandon Driver; Philip T Cagle
Journal:  Arch Pathol Lab Med       Date:  2018-04-30       Impact factor: 5.534

2.  A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.

Authors:  Jennifer W Koehler; Andrew D Miller; C Ryan Miller; Brian Porter; Kenneth Aldape; Jessica Beck; Daniel Brat; Ingrid Cornax; Kara Corps; Chad Frank; Caterina Giannini; Craig Horbinski; Jason T Huse; M Gerard O'Sullivan; Daniel R Rissi; R Mark Simpson; Kevin Woolard; Joanna H Shih; Christina Mazcko; Mark R Gilbert; Amy K LeBlanc
Journal:  J Neuropathol Exp Neurol       Date:  2018-11-01       Impact factor: 3.685

3.  Uncommon frequency of adenocarcinomas of the uterus in virgin Han:Wistar rats.

Authors:  F Deerberg; S Rehm; W Pittermann
Journal:  Vet Pathol       Date:  1981-11       Impact factor: 2.221

Review 4.  Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.

Authors:  Amy K LeBlanc; Christina Mazcko; Diane E Brown; Jennifer W Koehler; Andrew D Miller; C Ryan Miller; R Timothy Bentley; Rebecca A Packer; Matthew Breen; C Elizabeth Boudreau; Jonathan M Levine; R Mark Simpson; Charles Halsey; William Kisseberth; John H Rossmeisl; Peter J Dickinson; Timothy M Fan; Kara Corps; Kenneth Aldape; Vinay Puduvalli; G Elizabeth Pluhar; Mark R Gilbert
Journal:  Neuro Oncol       Date:  2016-05-14       Impact factor: 12.300

5.  Proliferative and nonproliferative lesions of the rat and mouse central and peripheral nervous systems.

Authors:  Wolfgang Kaufmann; Brad Bolon; Alys Bradley; Mark Butt; Stephanie Czasch; Robert H Garman; Catherine George; Sibylle Gröters; Georg Krinke; Peter Little; Jenny McKay; Isao Narama; Deepa Rao; Makoto Shibutani; Robert Sills
Journal:  Toxicol Pathol       Date:  2012-06       Impact factor: 1.902

6.  Proliferative and nonproliferative lesions of the rat and mouse urinary system.

Authors:  Kendall S Frazier; John Curtis Seely; Gordon C Hard; Graham Betton; Roger Burnett; Shunji Nakatsuji; Akiyoshi Nishikawa; Beate Durchfeld-Meyer; Axel Bube
Journal:  Toxicol Pathol       Date:  2012-06       Impact factor: 1.902

Review 7.  Cyclodextrins.

Authors:  Valentino J Stella; Quanren He
Journal:  Toxicol Pathol       Date:  2008-01       Impact factor: 1.902

8.  Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys.

Authors:  Masaya Baba; Mutsuo Furihata; Seung-Beom Hong; Lino Tessarollo; Diana C Haines; Eileen Southon; Vishal Patel; Peter Igarashi; W Gregory Alvord; Robert Leighty; Masahiro Yao; Marcelino Bernardo; Lilia Ileva; Peter Choyke; Michelle B Warren; Berton Zbar; W Marston Linehan; Laura S Schmidt
Journal:  J Natl Cancer Inst       Date:  2008-01-08       Impact factor: 13.506

9.  Primary squamous cell carcinoma of the endometrium in a woman of perimenopausal age: A case report.

Authors:  Chao Zhang; Hongyan Zhang; Linqing Yang; Yunfei Wang; Xiaoyu Li; Jinfeng Guo; Jing Xu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.